This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
HealthdirectFree Australian health advice you can count on.
INN: imatinib
Data updated: 2026-04-25
Available in:
🇩🇪🇬🇧🇯🇵🇵🇹
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Teva B.V.
ATC Code
L01XE01
Source
EMA · EMEA/H/C/004748
(
ARTG
)
- treatment of patients with chronic myeloid leukaemia (CML)
- treatment of adult patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukaemia (Ph+ ALL) integrated with chemotherapy
- treatment of adult patients with relapsed or refractory Ph+ ALL as monotherapy
- treatment of adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with platelet-derived growth factor receptor (PDGFR) gene re-arrangements, where conventional therapies have failed
- treatment of adult patients with aggressive systemic mastocytosis (ASM), where conventional therapies have failed
- treatment of adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukaemia (CEL)
- adult patients with unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans (DFSP).
⚠️ Warnings
•Caution should be exercised in patients with history of high blood pressure, heart attack, irregular heartbeat, diabetes, heart, lung, thyroid or liver disease, smokers, street drug and heavy alcohol users.
Avoid excess dosage.
It may cause diarrhea during the treatment. Consult with your doctor if it does so.
Consult with your doctor during pregnancy and breastfeeding.